These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. An integrative characterization of recurrent molecular aberrations in glioblastoma genomes. Sintupisut N; Liu PL; Yeang CH Nucleic Acids Res; 2013 Oct; 41(19):8803-21. PubMed ID: 23907387 [TBL] [Abstract][Full Text] [Related]
5. High-resolution genomic copy number profiling of glioblastoma multiforme by single nucleotide polymorphism DNA microarray. Yin D; Ogawa S; Kawamata N; Tunici P; Finocchiaro G; Eoli M; Ruckert C; Huynh T; Liu G; Kato M; Sanada M; Jauch A; Dugas M; Black KL; Koeffler HP Mol Cancer Res; 2009 May; 7(5):665-77. PubMed ID: 19435819 [TBL] [Abstract][Full Text] [Related]
6. Analysis of the cancer genome atlas (TCGA) database identifies an inverse relationship between interleukin-13 receptor α1 and α2 gene expression and poor prognosis and drug resistance in subjects with glioblastoma multiforme. Han J; Puri RK J Neurooncol; 2018 Feb; 136(3):463-474. PubMed ID: 29168083 [TBL] [Abstract][Full Text] [Related]
7. The importance of genomic copy number changes in the prognosis of glioblastoma multiforme. Arslantas A; Artan S; Oner U; Müslümanoğlu H; Durmaz R; Cosan E; Atasoy MA; Başaran N; Tel E Neurosurg Rev; 2004 Jan; 27(1):58-64. PubMed ID: 12845540 [TBL] [Abstract][Full Text] [Related]
8. Identification of prognostic gene signatures of glioblastoma: a study based on TCGA data analysis. Kim YW; Koul D; Kim SH; Lucio-Eterovic AK; Freire PR; Yao J; Wang J; Almeida JS; Aldape K; Yung WK Neuro Oncol; 2013 Jul; 15(7):829-39. PubMed ID: 23502430 [TBL] [Abstract][Full Text] [Related]
9. Comparative genomic and genetic analysis of glioblastoma-derived brain tumor-initiating cells and their parent tumors. Davis B; Shen Y; Poon CC; Luchman HA; Stechishin OD; Pontifex CS; Wu W; Kelly JJ; Blough MD; Neuro Oncol; 2016 Mar; 18(3):350-60. PubMed ID: 26245525 [TBL] [Abstract][Full Text] [Related]
10. Detection of multiple gene amplifications in glioblastoma multiforme using array-based comparative genomic hybridization. Hui AB; Lo KW; Yin XL; Poon WS; Ng HK Lab Invest; 2001 May; 81(5):717-23. PubMed ID: 11351043 [TBL] [Abstract][Full Text] [Related]
11. CDC6 is up-regulated and a poor prognostic signature in glioblastoma multiforme. Zhao H; Zhou X; Yuan G; Hou Z; Sun H; Zhai N; Huang B; Li X Clin Transl Oncol; 2021 Mar; 23(3):565-571. PubMed ID: 32661826 [TBL] [Abstract][Full Text] [Related]
12. Comprehensive analysis of Reverse Phase Protein Array data reveals characteristic unique proteomic signatures for glioblastoma subtypes. Patil V; Mahalingam K Gene; 2019 Feb; 685():85-95. PubMed ID: 30401645 [TBL] [Abstract][Full Text] [Related]
13. Uniform MDM2 overexpression in a panel of glioblastoma multiforme cell lines with divergent EGFR and p53 expression status. Halatsch ME; Schmidt U; Unterberg A; Vougioukas VI Anticancer Res; 2006; 26(6B):4191-4. PubMed ID: 17201132 [TBL] [Abstract][Full Text] [Related]
14. LncRNA and mRNA expression profiles of glioblastoma multiforme (GBM) reveal the potential roles of lncRNAs in GBM pathogenesis. Li Q; Jia H; Li H; Dong C; Wang Y; Zou Z Tumour Biol; 2016 Nov; 37(11):14537-14552. PubMed ID: 27604987 [TBL] [Abstract][Full Text] [Related]
15. Molecular heterogeneity in a patient-derived glioblastoma xenoline is regulated by different cancer stem cell populations. Garner JM; Ellison DW; Finkelstein D; Ganguly D; Du Z; Sims M; Yang CH; Interiano RB; Davidoff AM; Pfeffer LM PLoS One; 2015; 10(5):e0125838. PubMed ID: 25955030 [TBL] [Abstract][Full Text] [Related]
16. Multi-omics analysis of primary glioblastoma cell lines shows recapitulation of pivotal molecular features of parental tumors. Rosenberg S; Verreault M; Schmitt C; Guegan J; Guehennec J; Levasseur C; Marie Y; Bielle F; Mokhtari K; Hoang-Xuan K; Ligon K; Sanson M; Delattre JY; Idbaih A Neuro Oncol; 2017 Feb; 19(2):219-228. PubMed ID: 27571888 [TBL] [Abstract][Full Text] [Related]
17. Overexpressed Skp2 within 5p amplification detected by array-based comparative genomic hybridization is associated with poor prognosis of glioblastomas. Saigusa K; Hashimoto N; Tsuda H; Yokoi S; Maruno M; Yoshimine T; Aoyagi M; Ohno K; Imoto I; Inazawa J Cancer Sci; 2005 Oct; 96(10):676-83. PubMed ID: 16232199 [TBL] [Abstract][Full Text] [Related]
18. Proteomic profiling of patient-derived glioblastoma xenografts identifies a subset with activated EGFR: implications for drug development. Brown KE; Chagoya G; Kwatra SG; Yen T; Keir ST; Cooter M; Hoadley KA; Rasheed A; Lipp ES; Mclendon R; Ali-Osman F; Bigner DD; Sampson JH; Kwatra MM J Neurochem; 2015 Jun; 133(5):730-8. PubMed ID: 25598002 [TBL] [Abstract][Full Text] [Related]
19. Nuclear Respiratory Factor 1 (NRF1) Transcriptional Activity-Driven Gene Signature Association with Severity of Astrocytoma and Poor Prognosis of Glioblastoma. Bhawe K; Felty Q; Yoo C; Ehtesham NZ; Hasnain SE; Singh VP; Mohapatra I; Roy D Mol Neurobiol; 2020 Sep; 57(9):3827-3845. PubMed ID: 32594352 [TBL] [Abstract][Full Text] [Related]
20. DNA copy number variation and gene expression analyses reveal the implication of specific oncogenes and genes in GBM. Margareto J; Leis O; Larrarte E; Pomposo IC; Garibi JM; Lafuente JV Cancer Invest; 2009 Jun; 27(5):541-8. PubMed ID: 19219654 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]